ALV
0.047
104.3%
WLD
0.014
-51.7%
SRN
0.002
100%
MEL
0.001
-50%
MML
0.034
54.5%
QFE
0.067
-46.4%
C7A
0.003
50%
JNS
0.099
-41.8%
IRX
0.036
38.5%
SFX
0.072
-34.5%
1AI
0.012
33.3%
DRO
1.715
-34%
FRS
0.265
32.5%
CHM
0.002
-33.3%
ROC
0.165
32%
TEM
0.007
-30%
RAS
0.038
31%
ECS
0.005
-28.6%
ECL
4.31
30.6%
USL
0.49
-27.4%
CXU
0.022
29.4%
IFG
0.008
-27.3%
MRD
0.033
26.9%
RNV
0.115
-25.8%
GW1
0.038
26.7%
AI1
0.057
-25%
STM
0.024
26.3%
BIT
0.003
-25%
PMT
0.505
26.3%
KRR
0.012
-25%
BPM
0.17
25.9%
SPX
0.003
-25%
RKB
0.005
25%
ASN
0.079
-24.8%
TGN
0.155
24%
C29
0.019
-24%
GT1
0.037
23.3%
SVY
0.013
-23.5%
A11
0.22
22.2%
NC1
0.1
-23.1%
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

AVITA Medical (ASX:AVH) signed an exclusive 5 year distribution agreement with Stedical Scientific

AVITA Medical (ASX:AVH) signed an exclusive five year distribution agreement with Stedical Scientific, to commercialise PermeaDerm® Biosynthetic Wound Matrix in the U.S. The matrix is cleared by the U.S. FDA and used for a variety of injuries | https://announcements.asx.com.au/asxpdf/20240111/pdf/05zbp446ftpyw0.pdf #FDA #PermeaDerm #AVH